| Epigenomics of Common Diseases | |
|
United Kingdom - Wellcome Genome Campus |
|
| Hosted by: | Wellcome Genome Campus Scientific Conferences |
| Venue: | Wellcome Genome Campus |
| Dates: | Nov 01, 2016 through Nov 04, 2016 |
| Call for Proceedings Presentations: | 2016-01-01 through 2016-09-20 |
| Call for Posters: | 2016-01-01 through 2016-01-01 |
| Event Registration: | 2016-01-01 through 2016-10-04 |
|
Description |
|
| The 6th Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving area. Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. In addition, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established. This meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease. |
|
| Additional Information | |
| Event URL: | https://coursesandconferences.wellcomegenomecampus.org/Conferences.wt |
| ISCB Member Discount: | None |
| Contact Person: | Scientific Conferences Team ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
